Literature DB >> 24566401

18F-FDG PET/CT superscan in prostate cancer.

Matthieu Bailly1, Hélène Besse, Rémi Kerdraon, Gilles Metrard, Sabine Gauvain.   

Abstract

F-FDG PET/CT of a patient with inflammatory lower back pain reveals diffuse bony metastases, similar to the "superscan" found on a Tc-methylene diphosphonate scintigraphy, and also demonstrates a prostatic lesion which appears to be a poorly differentiated prostate adenocarcinoma.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24566401     DOI： 10.1097/RLU.0000000000000376

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  5 in total

1.  Technetium 99m PSMA Superscan Mimicking a Bone Scan Gone Wrong.

Authors:  Evbuomwan Osayande; Fourie Carika; Engelbrecht Gerrit
Journal:  Nucl Med Mol Imaging       Date:  2022-04-19

Review 2.  Clinical Pearls: Etiologies of Superscan Appearance on Fluorine-18-Fludeoxyglucose Positron Emission Tomography-Computed Tomography.

Authors:  John Joseph Manov; Patrick J Roth; Russ Kuker
Journal:  Indian J Nucl Med       Date:  2017 Oct-Dec

3.  Diffuse Skeletal Uptake on 18F-Fluoro-2-Deoxy-d-glucose Positron Emission Tomography/Computed Tomography Scan in a Patient with Acute Lymphoblastic Leukemia: A Typical Superscan Pattern Resembling NaF Positron Emission Tomography Scan.

Authors:  Abbas Yousefi-Koma; Yaser Shiravand; Mohsen Qutbi
Journal:  Indian J Nucl Med       Date:  2019 Oct-Dec

4.  Metastatic superscan in prostate carcinoma on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography scan.

Authors:  Krishan Kant Agarwal; Madhavi Tripathi; Rajeev Kumar; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun

5.  Superscan Appearance of 68Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer.

Authors:  Zehra Pınar Koç; Pınar Pelin Özcan; Vehbi Erçolak; Mehmet Reyhan
Journal:  Mol Imaging Radionucl Ther       Date:  2022-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.